Fierce Pharma
OCTOBER 7, 2024
With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their generic to Novo Nordisk's wildly popular Type 2 diabetes drug Ozempic. | Mylan Pharmaceuticals and Novo Nordisk have reached a confidential settlement in a patent lawsuit tied to generic Ozempic, also known as semaglutide, India’s Natco Pharma said.
MedCity News
OCTOBER 7, 2024
Months before the FTC sued the three largest pharmacy benefit managers, the CEO of Blue Shield of California battled its PBM – CVS Caremark – to bring a lower cost prostate cancer drug to its members. The post Video: Why the FTC’s Lawsuit Against PBMs May Have Some Legs appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 7, 2024
After winning a first-in-class nod for its two-drug inhaler Airsupra l | After winning a first-in-class nod for its two-drug inhaler Airsupra last January, AstraZeneca is bolstering the rescue treatment’s clinical package with new data showing it can cut the risk of asthma exacerbations regardless of patients’ disease severity.
European Pharmaceutical Review
OCTOBER 7, 2024
New results from a first-of-its-kind study reports that a CAR-T cell therapy provided similar efficacy and safety to relapsed or refractory multiple myeloma patients administered with the treatment in clinical trials. For example, of the 236 patients who received infusions of ciltacabtagene autoleucel (cilta-cel), data shows that 89 percent responded to the treatment.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Fierce Pharma
OCTOBER 7, 2024
GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | The long-acting HIV PrEP maker pledged to make at least 2 million more doses available for low-and middle-income countries in 2025 and 2026.
MedCity News
OCTOBER 7, 2024
Even top companies struggle to maintain adequate IT staffing levels. Here are several reasons why FQHCs should consider outsourcing to a firm experienced in the nuances of healthcare. The post Why Outsourcing IT and Cybersecurity is the Smart Choice for FQHCs appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Technology
OCTOBER 7, 2024
The CD7 CAR)-T cell therapy has demonstrated potential in treating patients with relapsed or refractory T-cell leukaemia.
Fierce Pharma
OCTOBER 7, 2024
In this interview, Kavitha Lokesh, Vice President of Global Life Sciences R&D Industry Solutions at Cognizant, discusses her role and the impact of precision medicine. | Kavitha Lokesh, VP of Global Life Sciences R&D Industry Solutions at Cognizant explains how data modernization and AI are key to the shift in personalized medicine, enabling better integration and analysis of diverse health data, enhancing patient care and outcomes.
PharmaVoice
OCTOBER 7, 2024
Through real-world data, an AI company found that popular weight loss drugs could be a preventive measure for patients at risk of heart attack and stroke.
Fierce Pharma
OCTOBER 7, 2024
After Kaléo unveiled a “redesign” of the in-office commercial team for its EpiPen rival Auvi-Q at the start of the month, the privately held company has announced a fresh round of job cuts in the U | After Kaléo unveiled a “redesign” of the in-office commercial team for its EpiPen rival Auvi-Q at the start of the month, the privately held company has announced a fresh round of job cuts across the U.S.
pharmaphorum
OCTOBER 7, 2024
UK Health Secretary Wes Streeting has announced plans to allow NHS England to share primary care data with scientific researchers, taking on some of the responsibility held by GPs. The minister told the Royal College of General Practitioners (RCGP) annual conference that, while many UK patients have given their consent for their data to be shared with studies run by the likes of the UK Biobank, Genomics England, and Our Future Health, they "still see, far too often, that this data is not shared
Pharmaceutical Technology
OCTOBER 7, 2024
The safety review was requested by the French medicines agency, citing new safety reports that alter the risk profile of finasteride.
ALULA
OCTOBER 7, 2024
The Billion-Dollar Question In today's fast-paced business environment, organizational resilience isn't just a buzzword—it's a key driver of success. Consider this: companies with high organizational resilience outperform their peers by an average of 30% in long-term shareholder returns.
MedCity News
OCTOBER 7, 2024
Perelel has acquired LOOM, an educational platform for reproductive health, sexual wellness and parenting. Through the acquisition, the company aims to advance health literacy for women. The post Perelel Acquires LOOM to Boost Women’s Health Education in Sexual, Reproductive Health appeared first on MedCity News.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
pharmaphorum
OCTOBER 7, 2024
Victor Ambros and Gary Ruvkun have shared this year's Nobel Prize in Physiology or Medicine for their discovery of microRNA
MedCity News
OCTOBER 7, 2024
Cardiovascular disease drugs in development intended to reduce lipoprotein (a) are mostly injectable medications, though Eli Lilly also has both oral and injectable drugs in the clinic. AstraZeneca aims to hit that key protein target with an oral small molecule licensed from CSPC Pharmaceutical Group. The post AstraZeneca Expands Cardiovascular Disease Prospects, Paying $100M for Oral Way to Drug Lp(a) appeared first on MedCity News.
pharmaphorum
OCTOBER 7, 2024
AstraZeneca pays $100m upfront for rights to an oral lipoprotein(a) drug developed by Chinese biotech CSPC Pharmaceutical.
PharmaTech
OCTOBER 7, 2024
The CDMO will be launching its EnzeneX 2.0 continuous manufacturing for biologics technology during CPHI Milan, which is being held Oct. 8–10, 2024 in Milan, Italy.
pharmaphorum
OCTOBER 7, 2024
A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy.The phase 3b BATURA study showed Airsupra (albuterol/budesonide) achieved a statistically significant reduction in the risk of severe asthma exacerbations when used as needed for rescue therapy compared to albuterol on its own.
Pharmaceutical Commerce
OCTOBER 7, 2024
In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenni Zilka, SVP, community & specialty pharmacy and president, Good Neighbor Pharmacy, explains how pending legislation can improve patient access, and how these are helping with recognizing pharmacists as HCPs.
PharmaTimes
OCTOBER 7, 2024
Biotech company moves forward with phase 2 trial for precision cancer surgery
Rep-Lite
OCTOBER 7, 2024
In the sales world, every industry has its unique challenges, and healthcare is no different. Dealing with complex regulations, different product lines, and changing market demands can be overwhelming. However, creating a strong sales strategy in healthcare is crucial because it affects patient care and the adoption of new medical solutions. The healthcare market is large and growing, fueled by technological advancements and an aging population that wants more comprehensive health services.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Marketing Network
OCTOBER 7, 2024
In the fiercely competitive pharmaceutical industry, effective brand positioning is crucial for marketers striving to distinguish their products and services. With an ever-evolving market landscape, pharmaceutical companies must develop robust strategies to position their brands distinctively. This article explores the intricacies of brand positioning strategies for pharma marketers, focusing on understanding brand positioning, identifying challenges, leveraging customer insights, and more.
PharmaTech
OCTOBER 7, 2024
Pharmaceutical Technology Europe sat down with Uwe Hanenberg, Head of Product Implementation at Recipharm, to talk about key trends shaping the oral solid dosage market, including technology advances and industry investments.
Spotio
OCTOBER 7, 2024
Looking for a Map My Customers alternative? You’ve come to the right place! Map My Customers is a popular field sales CRM-focused software that allows businesses to find leads, manage territories, map routes between prospects, and more. But it’s not the perfect solution for every sales team. In fact, it has certain limitations that you need to be aware of.
Referral MD
OCTOBER 7, 2024
Securing Patient Portals: Best Practices for Protecting Online Records 33.33% of patient portals have privacy concerns that create a sense of distrust among many providers and patients. What are the best practices for data security? Most healthcare organizations and other care providers still struggle to find the balance between offering an easy-to-use interface and maintaining data integrity.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Scott Burrows
OCTOBER 7, 2024
In the high-pressure world of healthcare, the ability to bounce back from adversity is paramount. As a former spinal cord injury patient who faced significant challenges, I’ve learned firsthand the importance of resilience—not only in my own life but also within the teams that deliver critical care. Today, I want to share insights from my journey that can help healthcare leaders foster resilience in their teams and combat the chronic stress and burnout that so many face.
PharmExec
OCTOBER 7, 2024
Approval was based on results from Phase I clinical safety studies, which demonstrated that using three tubes of Ameluz maintained similar safety and systemic exposure levels as one tube in treating actinic keratosis in patients undergoing photodynamic therapy.
Contrarian Sales Techniques
OCTOBER 7, 2024
Medical sales isn't just about pitching medicines or medical devices. It's understanding your audience, their needs, and the ever-evolving dynamics of healthcare. Whether you’re new to the game or a seasoned rep, these stories will give you insights, lessons, and maybe even a few laughs. From redemption tales to clever selling tactics, here are 11 must-read stories to inspire your sales journey. 1.
PharmExec
OCTOBER 7, 2024
The U.S. healthcare system has undergone significant changes, particularly in the pharmaceutical industry, due to factors like telemedicine, integrated delivery networks, and value-based care. This has challenged traditional sales models and increased the need for more strategic engagement with clinical executives.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Expert insights. Personalized for you.
307 
Let's personalize your content